Settling the Score: Saturday’s results

17 Comments

Saturday’s Nationals-Dodgers game had it all.

Nats ace Stephen Strasburg fanned nine batters and yielded just one run over seven stellar frames.

Nats phenom Bryce Harper made his major league debut, tallying his first hit (a double to center), his first RBI (on a sacrifice fly) and showing off his elite arm with a missile from left field to home plate.

But it was baseball’s best all-around player who ultimately stole the show. After being stymied in three at-bats against Strasburg, Dodgers outfielder Matt Kemp launched a Tom Gorzelanny pitch deep into the night to give Los Angeles a 4-3 walkoff win in the bottom of the 10th inning at Chavez Ravine. Kemp is now batting .442/.506/.922 with 11 home runs and 24 RBI in 21 games. He’s on another planet, people.

Your Saturday box scores:

Nationals 3, Dodgers 4

Angels 2, Indians 1

Brewers 3, Cardinals 7

Tigers 7, Yankees 5

Mariners 0, Blue Jays 7

Astros 0, Reds 6

Athletics 1, Orioles 10

Cubs 2, Phillies 5

Red Sox 1, White Sox 0

Pirates 4, Braves 2

Diamondbacks 2, Marlins 3

Rays 2, Rangers 7

Mets 7, Rockies 5

Padres 1, Giants 2

Royals, Twins (Postponed)

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.